RECENT efforts by health authorities in Australia to restrict testing for levels of vitamin D in patients has been described as a "blunt instrument" in a research article by University of Adelaide authors Dr David Gonzalez-Chica and Professor Nigel Stocks.
Taking data from the National Prescribing Service MedicineInsight database, the authors concluded that even though the measures taken to restrict vitamin D testing in 2014 have almost halved its frequency, the measure had "also lessened the frequency of testing among those at higher risk of deficiency, with only a small improvement in vitamin D deficiency detection".
The study investigated 1.5million 'active' patients aged 18+ years in the primary care setting - bmj.com.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Mar 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Mar 19
